Why Asuragen Chooses Seraseq® ctDNA V2

Asuragen relies on SeraCare’s liquid biopsy products to help streamline sensitive assays and workflows in order to produce high-quality results. Associate Director of Bioinformatics at Asuragen, Brian Haynes, PhD, talks about the importance of high-quality, patient-like reference materials and LOD experiments.

We’re basically getting more bang for our buck from those reference materials because they have more mutations representing within them. – Brian Haynes, PhD

Watch this video to hear about his experience working with Seraseq ctDNA V2 in the lab. 


See what others are saying about SeraCare by visiting our Customer Stories.

Related Content